TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells

Arthritis Research and Therapy

Volumn 8, Issue 5, 2006, Pages

  Ando, Takashi ^a   Ichikawa, Jiro ^a   Wako, Masanori ^a   Hatsushika, Kyosuke ^a   Watanabe, Yoshiyuki ^a   Sakuma, Michitomo ^a   Tasaka, Kachio ^a   Ogawa, Hideoki ^b   Hamada, Yoshiki ^a   Yagita, Hideo ^b   Nakao, Atsuhito ^a,b  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BMP2 PROTEIN, HUMAN; BMP2 PROTEIN, MOUSE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RANTES; RECOMBINANT PROTEIN; TNFSF11 PROTEIN, HUMAN; TNFSF11 PROTEIN, MOUSE; TNFSF12 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TWEAK RECEPTOR;

3T3 CELL LINE; ANIMAL; CELL DIFFERENTIATION; CHIMERA; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MOUSE; OSTEOBLAST; PHYSIOLOGY; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CHEMOKINE CCL5; CHIMERA; GENE EXPRESSION; HUMANS; MICE; OSTEOBLASTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RANK LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTORS;

EID: 70249126873     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2038     Document Type: Article

References (22)

1. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, Browning JL: TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 1997, 272:32401-32410.
2. Wiley SR, Winkles JA: TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokine Growth Factor Rev 2003, 14:241-249.
3. Campbell S, Michaelson J, Burkly L, Putterman C: The role of TWEAK/ Fn14 in the pathogenesis of inflammation and systemic autoimmunity. Front Biosci 2004, 9:2273-2284.
4. Meighan-Mantha RL, Hsu DK, Guo Y, Brown SA, Feng SL, Peifley KA, Alberts GF, Copeland NG, Gilbert DJ, Jenkins NA, et al.: The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J Biol Chem 1999, 274:33166-33176.
5. Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkeles JA, Lindner V, Liu H, Daniel TO, Smith CA, Fanslow WC: A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 2001, 15:837-846.
6. Saitoh T, Nakayama M, Nakano H, Yagita H, Yamamoto N, Yamaoka S: TWEAK induces NF-κB2 p100 processing and long-lasting NF-κB activation J Biol Chem 2003, 278:36005-36012.
7. Donohue PJ, Richards CM, Brown SA, Hanscom HN, Buschman J, Thangada S, Hla T, Williams MS, Winkles JA: TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity. Arterioscler Thromb Vasc Biol 2003, 23:594-600.
8. Harada N, Nakayama M, Nakano H, Fukuchi Y, Yagita H, Okumura K: Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Biochem Biophys Res Commun 2002, 299 488-493.
9. Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, Okumura K, Yagita H: Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death. J Immunol 2003, 170:341-348.
10. Jin L, Nakao A, Nakayama M, Yamaguchi N, Kojima Y, Nakano N, Tsuboi R, Okumura K, Yagita H, Ogawa H: Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes. J Invest Dermatol 2004, 122:1175-1179.
11. Xu H, Okamoto A, Ichikawa J, Ando T, Tasaka K, Masuyama K, Ogawa H, Yagita H, Okumura K, Nakao A: TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF. Biochem Biophys Res Commun 2004, 318:422-427.
12. Polek TC, Talpaz M, Darnay BG, Spvak-Kroizman T: TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. J Biol Chem 2003, 278:32317-32323.
13. Kodama HA, Amagai Y, Yamamoto S, Kasai S: In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 1983, 96:191-198.
14. Kanamaru Y, Sumiyoshi K, Ushio H, Ogawa H, Okumura K, Nakao A: Smad3 deficiency in mast cells provides efficient host protection against acute septic peritonitis. J Immunol 2005, 174:4193-4197.
15. Reddi AH: Bone and cartilage differentiation. Curr Opin Genet Dev 1994, 4:737-744.
16. Hogan BL: Bone morphogeMetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996, 10:1580-1594.
17. Hiraki Y, Inoue H, Shigeno C, Sanma Y, Bentz H, Rosen DM, Asada A, Suzuki F: Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro. J Bone Miner Res 1991, 6:1373-1385.
18. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, et al.: Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc Natl Acad Sci USA 1998, 95:3597-3602.
19. Yu X, Huang Y, Collin-Osdoby P, Osdoby P: CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res 2004, 19:2065-2077.
20. De Ketelaere A, Vermeulen L, Vialard J, Van De Weyer I, Van Wauwe J, Haegeman G, Moelans I: Involvement of GSK-3beta in TWEAK-mediated NF-kappaB activation. FEBS Lett 2004, 566:60-64.
21. Tamura Y, Takeuchi Y, Suzawa M, Fukumoto S, Kato M, Miyazono K, Fujita T: Focal adhesion kinase activity is required for bone morphogenetic protein-Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells. J Bone Miner Res 2001, 16:1772-1779.
22. Kretzschmar M, Doody J, Massague J: Opposing BMP and EGF signalling pathways converge on the TGF-β family mediatorSmad1. Nature 1997, 389:618-622.